Compounds that act to modulate insect growth and methods and systems for identifying such compounds
申请人:Henrich C. Vincent
公开号:US20050049230A1
公开(公告)日:2005-03-03
Disclosed are methods and systems for screening for compounds that act to modulate insect growth. Bioassays including cell culture and/or transgenic insects engineered with various components of the ecdysoid receptor (EcR) and/or the farsenoid-X receptor (RXR) systems to identify compounds that act as insecticides and/or hormone receptor activators are described. Also described are compounds, and compositions, identified as being putative insecticides based upon their ability to activate EcR and/or FXR mediated transcription.
Compounds That Act To Modulate Insect Growth And Methods And Systems For Identifying Such Compounds
申请人:Henrich Vincent C.
公开号:US20110207707A1
公开(公告)日:2011-08-25
Disclosed are methods and systems for screening for compounds that act to modulate insect growth. Bioassays including cell culture and/or transgenic insects engineered with various components of the ecdysoid receptor (EcR) and/or the farsenoid-X receptor (RXR) systems to identify compounds that act as insecticides and/or hormone receptor activators are described. Also described are compounds, and compositions, identified as being putative insecticides based upon their ability to activate EcR and/or FXR mediated transcription.
Medical Delivery Devices and Methods for Applying a Barrier Composition to a Targeted Skin Surface
申请人:Preventamedics LLC
公开号:US20150050366A1
公开(公告)日:2015-02-19
Some embodiments of a system or method for applying a barrier composition to a targeted skin surface can be used to as a preventative measure to reduce the likelihood of transmission of microbial entities from an external source (e.g., a floor surface or another surface) to the targeted skin surface.
alpha-Bisabolol beta-D-fucopyranoside, a cytotoxic naturally occurring compound, was efficiently synthesized along with five other alpha-bisabolol glycosides (beta-D-glucoside, beta-D-galactoside, alpha-D-mannoside, beta-D-Xyloside and alpha-L-rhamnoside). Glycosidation of ot-bisabolol was performed using Schmidt's inverse procedure and provided excellent yields (83-95%). Cytotoxicity was evaluated against a broad panel of cancerous cell lines including human and rat glioma (U-87, U-251 and GL-261) since the anticancer activity of alpha-bisabolol was previously demonstrated against brain tumor cell lines. The addition of a sugar moiety markedly increased alpha-bisabolol cytotoxicity in most cases. Among the synthesized glycosides, alpha-bisabolol alpha-L-rhamnopyranoside exhibited the strongest cytotoxic activity with IC50 ranging from 40 to 64 mu M. According to ADME in silico predictions, this glycoside closely respects physicochemical parameters necessary to cross the blood-brain barrier passively. (C) 2008 Elsevier Ltd. All rights reserved.
Anti-Tumour Terpene Compounds
申请人:Bowen Delme Ifor
公开号:US20070259056A1
公开(公告)日:2007-11-08
The present invention relates to the use of a terpene compound in the treatment or prophylaxis of cancer. The present invention also relates to a pharmaceutical composition comprising the terpene compound and a pharmaceutically acceptable excipient, carrier, adjuvant or vehicle.